Sylvie Mader

7PUBLICATIONS
55CO-AUTHORS
Cancer cell biologyGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2026
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.

Jasmin Coulombe-Huntington, Thierry Bertomeu, Caroline Huard

|Jun 12, 2025
CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity.

Marcelo M Rodriguez, Debashree Chatterjee, Johanna Guerry

|Oct 16, 2024
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition.

Roberto Piva, Nariman Gharari, Maria Labrador

|Nov 11, 2022
CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3.

Lucas Porras, Faustine Gorse, Ndeye Khady Thiombane

|Nov 27, 2021
Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis.

Lucas Porras, Houssam Ismail, Sylvie Mader

Pageof 2